Therapixel today said it received FDA 510(k) clearance for its MammoScreen artificial intelligence-used software. MammoScreen automatically detects and characterizes suspicious soft tissue lesions and calcifications in mammogram images while assessing malignancy. The results are then presented in a summary report that characterizes suspiciousness of lesions on a scale of 1 to 10, with one being […]